Changing patterns of relapse in Hodgkin's disease
Open Access
- 1 August 1989
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 60 (2) , 227-230
- https://doi.org/10.1038/bjc.1989.257
Abstract
The patterns of early and late relapses (those occurring later than 3 years after diagnosis) in 432 patients achieving complete remission after treatment for stage I and II Hodgkin's disease at the Royal Marsden Hospital between 1964 and 1983 were studied to identify factors predicting for late relapse. The incidence of early relapse has fallen progressively in recent treatment eras as staging procedures and management have improved but in contrast there has been no decrease in the risk of late relapse. The incidence of late relapse was greater in patients treated with radiotherapy rather than combined modality therapy (P less than 0.05). However, patients who were clinically staged and treated with combined modality therapy retained as high a risk of relapse between 3 and 6 years as in years 2 and 3. The risk of late relapse was also greater in patients with stage II disease and in those without B symptoms at presentation. Patients falling into the higher risk categories for late relapse require continued close follow-up beyond 3 years to monitor for possible relapse.Keywords
This publication has 13 references indexed in Scilit:
- An analysis of prognostic factors in early stage Hodgkin's diseaseRadiotherapy and Oncology, 1986
- REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEXThe Lancet, 1985
- Prognostic groups for management of localized Hodgkin's disease.Journal of Clinical Oncology, 1985
- Late Relapse Among Patients Treated for Hodgkin's DiseaseAnnals of Internal Medicine, 1985
- The EORTC treatment of early stages of hodgkin's disease: The role of radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1984
- THE MANAGEMENT OF STAGE-I-II HODGKINS-DISEASE WITH IRRADIATION ALONE OR COMBINED MODALITY THERAPY - THE STANFORD EXPERIENCE1982
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's diseaseBritish Journal of Cancer, 1979
- Initial relapses in previously treated Hodgkin's disease.I. Results of second treatmentCancer, 1976
- Prognostic indicators in Hodgkin's diseaseCancer, 1972